Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pusan National University Hospital | OTHER |
The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmaceutical care | Experimental | Participants received systematically organized pharmaceutical care services, which were provided by pharmacists, in addition to the usual care. The usual care includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian. |
|
| Usual care | No Intervention | Participants received the usual care, which includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pharmaceutical care | Behavioral | Outpatient drug history management, drug regimen review, patient counseling and education before and/or after physician evaluation on the day of facility visit |
| Measure | Description | Time Frame |
|---|---|---|
| Medications knowledge at 9 months | Patients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects. | 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| HbA1c level at 9 months | 9 months | |
| Random blood glucose level at 9 months | 9 months | |
| Blood pressure at 9 months |
Not provided
Inclusion Criteria: Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria
Exclusion Criteria: Patients who meet one of the following criteria
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Sep 9, 2018 | |
| Reset | Feb 5, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Sep 9, 2018 | Feb 5, 2019 |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010593 | Pharmaceutical Services |
| ID | Term |
|---|---|
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 9 months |
| Cholesterol level at 9 months | 9 months |
| Proportion of participants taking statins 9 months | 9 months |
| Proportion of participants managing diabetes complications at 9 months | 9 months |
| Morisky Medication Adherence Scale at 9 months | 9 months |
| 5-level version of the EQ-5D at 9 months | 9 months |
| EQ Visual Analogue Scale at 9 months | 9 months |
| Problem Areas In Diabetes-Korean questionnaire at 9 months | 9 months |
| Patient Satisfaction Questionnaire-Korean at 9 months | 9 months |
| Cost-effectiveness of pharmaceutical care at 9 months | 9 months |
| D004700 | Endocrine System Diseases |